Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-25-020884
Filing Date
2025-03-05
Accepted
2025-03-05 16:15:51
Documents
14
Period of Report
2025-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm258385d1_8ka.htm   iXBRL 8-K/A 39589
2 EXHIBIT 2.1 tm258385d1_ex2-1.htm EX-2.1 547067
  Complete submission text file 0001104659-25-020884.txt   887698

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20250304.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20250304_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20250304_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT tm258385d1_8ka_htm.xml XML 3682
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-35867 | Film No.: 25711239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)